Repare Therapeutics Inc. Total Assets
Repare Therapeutics Inc. had Total Assets of $126.75 million as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2025-11-14
- 2025-09-30: Assets $126.75M.
- 2025-06-30: Assets $130.49M.
- 2025-03-31: Assets $144.02M.
- 2024-12-31: Assets $176.51M.
| Period end | Assets |
|---|---|
| 2025-09-30 | $126.75M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $130.49M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $144.02M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $176.51M 10-Q · filed 2025-11-14 |
| 2024-09-30 | $206.39M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $235.34M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $263.08M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $253.90M 10-K · filed 2025-03-03 |
| 2023-09-30 | $286.41M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $301.59M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $336.31M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $364.07M 10-K · filed 2024-02-28 |
| 2022-09-30 | $409.16M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $308.04M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $337.15M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $368.71M 10-K · filed 2023-02-28 |
| 2021-09-30 | $295.64M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $320.65M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $339.07M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $357.09M 10-K · filed 2022-03-01 |
| 2020-09-30 | $370.24M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $381.73M 10-Q · filed 2020-08-13 |
| 2019-12-31 | $102.69M 10-K · filed 2021-03-04 |